AHI M22 (Methyldopa 250 mg)

Pill imprint AHI M22 has been identified as Methyldopa 250 mg.

Methyldopa is used in the treatment of high blood pressure; hypertensive emergency and belongs to the drug class antiadrenergic agents, centrally acting. Risk cannot be ruled out during pregnancy. Methyldopa 250 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for AHI M22 (Methyldopa 250 mg)

Methyldopa
Imprint:
AHI
M22
Strength:
250 mg
Color:
Peach
Shape:
Round
Availability:
Prescription only
Drug Class:
Antiadrenergic agents, centrally acting
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Accord Healthcare, Inc.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web3)